James T. Joins Mavengity as a Medical Writer
With James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article$54 trillion is projected to pass to surviving spouses, mostly women, through 2048. The money is already at the firm. The industry's real problem is that it loses the account in the year of the transfer, not acquiring it.
Standard retirement advice, cash buffers, glide paths, is built around a volatility figure that treats gains and losses as equivalent. For a retiree who is spending, they are not, and the real risk lives in the sequence.
The IRS says UnitedHealth underpaid taxes by shifting money through a foreign subsidiary. The dispute isn't really about a number, it's about which reconstructed price for an internal transaction a court will accept.
Valisure is suing the standards body USP over a white paper it says disparaged its testing methods. Neither party sells pills. Both sell a claim about drug safety, and the lawsuit is a fight over whose word counts.
Chime tops the 2026 customer reputation ranking of U.S. banks, but it holds no charter. The reputation and the regulatory scrutiny belong to different companies, and the survey only measures one of them.
Out-of-state banks are buying up Texas franchises at a rapid clip. The same openness that built the state's banking boom is what makes its own banks impossible to protect from being bought.
Physician practice deals labeled private equity fell from 851 to 105 as states cracked down. But the new laws police a label, and the same consolidation can happen under a name the statutes do not reach.
North Carolina's Healthy Opportunities Pilots saved Medicaid $164 per member per month, but the program ran out of funding before that proof existed. Its history is a warning for anyone who wants to scale it.
RTX's $22.9 billion Tomahawk contract reads like a war dividend, but the missiles were always going to need replacing. The rally is pricing the end of a 25-year deferral, not new demand.
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
With James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the ArticleEvery article on Mavengity is written by a dedicated topic desk and checked against current market practice.
Home, auto, life, and health coverage, explained clearly and checked against the fine print.
Browse InsuranceRates, refinancing, and first-time buyer strategy, without the jargon lenders assume you already know.
Browse MortgageBudgeting, saving, and everyday money habits that compound. No get-rich-quick promises.
Browse Personal FinanceContracts, consumer rights, and disputes, explained so you know where you stand.
Browse LegalHealth coverage and medical billing, broken down so surprise bills are less likely to surprise you.
Browse HealthcareGartner and Forrester categories for B2B, translated into plain-English analysis for buyers, not analyst-subscription holders.
Browse ResearchWe start from public rate filings, regulator guidance, and lender disclosures, not marketing copy.
If a term needs a footnote, we explain it in the sentence instead of hiding it in the fine print.
We flag trade-offs and blind spots, not just the upside, so you get the full picture before you decide.
Mavengity is reader-supported and editorially independent from the products we cover.